NCT05645510 LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
| NCT ID | NCT05645510 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Alberta |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2022-11-24 |
| Primary Completion | 2026-06-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2022-11-24 with a primary completion date of 2026-06-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.
Eligibility Criteria
Inclusion Criteria: taking chronic targeted anti-cancer agents - Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05645510 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 90 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05645510 currently recruiting?
Yes, NCT05645510 is actively recruiting participants. Contact the research team at pituskin@ualberta.ca for enrollment information.
Where is the NCT05645510 trial being conducted?
This trial is being conducted at Edmonton, Canada.
Who is sponsoring the NCT05645510 clinical trial?
NCT05645510 is sponsored by University of Alberta. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.